Anti-Complement factor 8 beta/C8B antibody [EPR23764-1]
- BOND RX™ Validated
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal CO8B antibody. Suitable for IP, WB, IHC-P and reacts with Human, Recombinant full length protein - Human samples. Cited in 1 publication.
View Alternative Names
Complement component C8 beta chain, Complement component 8 subunit beta, C8B
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Complement factor 8 beta/C8B antibody [EPR23764-1] (AB278045)
Immunohistochemical analysis of paraffin-embedded human thyroid tissue labeling Complement factor 8 beta/C8B with ab278045 at 1/1000 (0.533 μg/ml) dilution followed by a ready to use secondary antibody. Positive staining on the blood plasma in human thyroid (PMID : 9476128). The section was incubated with ab278045 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND®RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use secondary antibody.
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Complement factor 8 beta/C8B antibody [EPR23764-1] (AB278045)
Immunohistochemical analysis of paraffin-embedded human cerebrum tissue labeling Complement factor 8 beta/C8B with ab278045 at 1/1000 (0.533 μg/ml) dilution followed by a ready to use secondary antibody. The section was incubated with ab278045 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Negative control : no staining on human cerebrum.
Secondary antibody only control : Secondary antibody is a ready to use secondary antibody.
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Complement factor 8 beta/C8B antibody [EPR23764-1] (AB278045)
Immunohistochemical analysis of paraffin-embedded human liver tissue labeling Complement factor 8 beta/C8B with ab278045 at 1/1000 (0.533 μg/ml) dilution followed by a ready to use secondary antibody. Cytoplasmic staining on human liver. The section was incubated with ab278045 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use secondary antibody).
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins.
- IP
Supplier Data
Immunoprecipitation - Anti-Complement factor 8 beta/C8B antibody [EPR23764-1] (AB278045)
Complement factor 8 beta/C8B was immunoprecipitated from 0.35 mg human kidney tissue lysate with ab278045 at 1/30 dilution (2μg in 0.35 mg lysates). Western blot was performed on the immunoprecipitate using ab278045 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP)(ab131366) was used at 1/5000 dilution.
Lane 1 : Human kidney tissue lysate 10 μg
Lane 2 : ab278045 IP in human kidney tissue lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab278045 in human kidney tissue lysate
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 3 minutes.
All lanes:
Immunoprecipitation - Anti-Complement factor 8 beta/C8B antibody [EPR23764-1] (ab278045)
Predicted band size: 67 kDa
Observed band size: 67 kDa
false
- WB
Lab
Western blot - Anti-Complement factor 8 beta/C8B antibody [EPR23764-1] (AB278045)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
The observed MW is consistent with what has been described in the literature (PMID : 21750743).
Negative : human brain (PMID : 16483657, PMID : 27005612).
Exposure time : 3 minutes.
All lanes:
Western blot - Anti-Complement factor 8 beta/C8B antibody [EPR23764-1] (ab278045) at 1/1000 dilution
Lane 1:
Human kidney tissue lysate at 20 µg
Lane 2:
Human liver tissue lysate at 20 µg
Lane 3:
Human large intestine tissue lysate at 20 µg
Lane 4:
Human brain tissue lysate at 20 µg
Secondary
All lanes:
VeriBlot for IP secondary antibody(HRP)(<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/1000 dilution
Predicted band size: 67 kDa
Observed band size: 67 kDa
false
- WB
Lab
Western blot - Anti-Complement factor 8 beta/C8B antibody [EPR23764-1] (AB278045)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
The observed MW is consistent with what has been described in the literature (PMID : 21750743).
Exposure time : 15 seconds.
All lanes:
Western blot - Anti-Complement factor 8 beta/C8B antibody [EPR23764-1] (ab278045) at 1/1000 dilution
All lanes:
Human serum at 20 µL
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Predicted band size: 67 kDa
Observed band size: 67 kDa
false
- WB
Lab
Western blot - Anti-Complement factor 8 beta/C8B antibody [EPR23764-1] (AB278045)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
This antibody has no cross reaction with human C8A and C9.
Sample loaded onto lane 1 was purified protein extracted from HEK293 expressing C8B, which contains a LIF-tag (40 kDa).
C8A and C9 recombinant proteins were expressed in E.coil expression systems.
Exposure time : 26 seconds.
All lanes:
Western blot - Anti-Complement factor 8 beta/C8B antibody [EPR23764-1] (ab278045) at 1/1000 dilution
Lane 1:
LIF-tagged human C8B recombinant protein, 30 ng
Lane 2:
E.coli extracts containing his-tagged human C8A recombinant protein, 30 ng
Lane 3:
E.coli extracts containing his-tagged human C9 recombinant protein, 30 ng
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution
Predicted band size: 67 kDa
false
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The C8B protein facilitates the stabilization of the C8 complex which also consists of the alpha and gamma chains to perform its role in the immune system. It plays an important role in forming the MAC an important structure for lysing pathogenic cells like bacteria by disrupting their plasma membranes. This action highlights the importance of C8B in innate immunity where it enables the host to eliminate harmful cells effectively.
Pathways
C8B's activities are integral to the complement cascade specifically within the terminal membrane attack pathway. It functions in conjunction with other complement factors like complement factor 5 to 9 forming a cascade of sequential activations. C8B works closely with complement factor 8 alpha and complement factor C5 within this pathway to achieve effective immune responses. These interactions ensure the proper function of the immune surveillance mechanism allowing the organism to protect itself against microbial infections.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
iScience 26:106417 PubMed37153444
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com